Evidence map›Paper›PMID 40640890›Full record

ReviewJournal of translational medicine2025

Remodeling and repair of the damaged brain: the potential and challenges of organoids for ischaemic stroke.

Yi-Xuan Hao, Chen-Rui Li, Zhi-Jie Lu, Nan Kong, Rong-Hua Huang, Shu-Yan Ma, Wen-Fei Zhou, Hao Jiao, Yue Qiu, Yuan-Feng Yu and 4 more

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. AScience signaling · 2026
    Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yi-Xuan Hao *Department of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, NO.57 Changping Road, Jinping District, Shantou, 515041, Guangdong, China.
Chen-Rui Li *Department of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, NO.57 Changping Road, Jinping District, Shantou, 515041, Guangdong, China.
Zhi-Jie Lu *Department of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, NO.57 Changping Road, Jinping District, Shantou, 515041, Guangdong, China.
Nan KongDepartment of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, NO.57 Changping Road, Jinping District, Shantou, 515041, Guangdong, China.
Rong-Hua HuangDepartment of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, NO.57 Changping Road, Jinping District, Shantou, 515041, Guangdong, China.
Shu-Yan MaDepartment of Anesthesiology, Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang, China.
Wen-Fei ZhouDepartment of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, NO.57 Changping Road, Jinping District, Shantou, 515041, Guangdong, China.
Hao JiaoDepartment of Anorectal Ward 3rd, Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang, China.
Yue QiuDepartment of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, NO.57 Changping Road, Jinping District, Shantou, 515041, Guangdong, China.
Yuan-Feng YuDepartment of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, NO.57 Changping Road, Jinping District, Shantou, 515041, Guangdong, China.
Bing-Wei LvDepartment of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, NO.57 Changping Road, Jinping District, Shantou, 515041, Guangdong, China.
Hai-Liang TangDepartment of Neurosurgery, Fudan University Huashan Hospital, Shanghai Medical College Fudan University, No.12 Urumqi Middle Road, Jing'an District, Shanghai, 200040, China. 081105229@fudan.edu.cn.
Jian ChenDepartment of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, NO.57 Changping Road, Jinping District, Shantou, 515041, Guangdong, China. dr.sword@163.com.
Nai-Li WeiDepartment of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, NO.57 Changping Road, Jinping District, Shantou, 515041, Guangdong, China. nlwei@stu.edu.cn.

Funding

Guangdong Basic and Applied Basic Research Foundation 2023B1515230008National Natural Science Foundation of China 82001447Natural Science Foundation of Guangdong Province 2214050005144Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province 210728166901906Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province STKJ2021075
6 · The paper itself

Abstract

Ischemic stroke induces irreversible cerebral tissue damage, a condition exacerbated by the brain's limited endogenous neuroplasticity and inability to regenerate neurons. While neural circuit reorganization holds therapeutic potential, its efficacy is hindered by pathological barriers such as glial scarring, chronic inflammation, and neurotrophic factor deficiency. Although pharmacological and interventional methods for stroke have been well developed, their functional recovery outcomes remain suboptimal. Emerging neural regeneration paradigms, particularly stem cell-based strategies (encompassing neural stem cell transplantation, neural progenitors grafts, and 3D brain organoid implantation), offer novel solutions to these challenges. However, critical limitations persist in conventional stem cell approaches: (1) compromised synaptic integration efficacy hinders functional neural circuit reconstruction; (2) the absence of functional vascular niches coupled with deficient astrocyte-mediated support and extracellular matrix signaling; (3) restricted regenerative capacity despite theoretical multipotent differentiation potential. Recent breakthroughs in cerebral organoid technology have revolutionized neurological disease modeling and neural repair research. Building upon this paradigm shift, our study mechanistically interrogates neuroplastic remodeling processes following ischemic stroke, while critically evaluating the therapeutic efficacy and inherent limitations of stem cell-based interventions. This affirms the critical role of 3D human cerebral organoid transplantation in the reconstruction of neural circuits. Additionally, we further summarize the utility of organoid-based disease models and address associated ethical and societal concerns. Future efforts should prioritize the clinical translation of organoid transplantation for ischemic stroke, aiming to mitigate neurological deficits and restore functional recovery.

Indexed as

BrainIschemic StrokeOrganoidsAnimalsHumansNeuronal PlasticityIschaemic strokeNeurological recoveryNeuroplasticityOrganoid transplantationRegenerative medicineStem cell therapy

Identifiers

PMID40640890
PMCPMC12247448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.